{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:41:50Z","timestamp":1793727710369,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12920-018-0354-x","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T03:42:56Z","timestamp":1522813376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["HLA and proteasome expression body map"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-8304","authenticated-orcid":false,"given":"Sebastian","family":"Boegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"L\u00f6wer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bukur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Castle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"354_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter S, Vormehr M, van de Roemer N, Diken M, L\u00f6wer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 2015;520:692\u20136. https:\/\/doi.org\/10.1038\/nature14426 .","journal-title":"Nature"},{"key":"354_CR2","doi-asserted-by":"publisher","first-page":"e26491","DOI":"10.4161\/onci.26491","volume":"2","author":"G Kochan","year":"2013","unstructured":"Kochan G, Escors D, Breckpot K, Guerrero-Setas D. Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology. 2013;2:e26491. https:\/\/doi.org\/10.4161\/onci.26491 .","journal-title":"Oncoimmunology"},{"key":"354_CR3","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/jnci\/djt184","volume":"105","author":"P Leone","year":"2013","unstructured":"Leone P, Shin E-C, Perosa F, Vacca A, Dammacco F, Racanelli V. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J Natl Cancer Inst. 2013;105:1172\u201387. https:\/\/doi.org\/10.1093\/jnci\/djt184 .","journal-title":"J Natl Cancer Inst"},{"key":"354_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma MLM, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011;11:823\u201336. https:\/\/doi.org\/10.1038\/nri3084 .","journal-title":"Nat Rev Immunol"},{"key":"354_CR5","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1158\/1078-0432.CCR-12-3697","volume":"19","author":"G Curigliano","year":"2013","unstructured":"Curigliano G, Criscitiello C, Gelao L, Goldhirsch A. Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res. 2013;19:5564\u201371. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3697 .","journal-title":"Clin Cancer Res"},{"key":"354_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5:621\u20138. https:\/\/doi.org\/10.1038\/nmeth.1226 .","journal-title":"Nat Methods"},{"key":"354_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1534\/g3.114.015784","volume":"5","author":"DY Brandt","year":"2015","unstructured":"Brandt DY, Aguiar VR, Bitarello BD, Nunes K, Goudet J, Meyer D. Mapping Bias overestimates reference allele frequencies at the HLA genes in the 1000 genomes project phase I data. G3 (Bethesda). 2015;5:931\u201341. https:\/\/doi.org\/10.1534\/g3.114.015784 .","journal-title":"G3 (Bethesda)"},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/gm403","volume":"4","author":"S Boegel","year":"2012","unstructured":"Boegel S, L\u00f6wer M, Sch\u00e4fer M, Bukur T, de Graaf J, Boisgu\u00e9rin V, et al. HLA typing from RNA-Seq sequence reads. Genome Med. 2012;4:102. https:\/\/doi.org\/10.1186\/gm403 .","journal-title":"Genome Med"},{"key":"354_CR9","doi-asserted-by":"publisher","first-page":"e954893","DOI":"10.4161\/21624011.2014.954893","volume":"3","author":"S Boegel","year":"2014","unstructured":"Boegel S, L\u00f6wer M, Bukur T, Sahin U, Castle JC. A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology. 2014;3:e954893. https:\/\/doi.org\/10.4161\/21624011.2014.954893 .","journal-title":"Oncoimmunology"},{"key":"354_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/ng.3312","volume":"47","author":"I Lappalainen","year":"2015","unstructured":"Lappalainen I, Almeida-King J, Kumanduri V, Senf A, Spalding JD, Ur-Rehman S, et al. The European genome-phenome archive of human data consented for biomedical research. Nat Genet. 2015;47:692\u20135. https:\/\/doi.org\/10.1038\/ng.3312 .","journal-title":"Nat Genet"},{"key":"354_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13073-015-0240-5","volume":"7","author":"J Scholtalbers","year":"2015","unstructured":"Scholtalbers J, Boegel S, Bukur T, Byl M, Goerges S, Sorn P, et al. TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. Genome Med. 2015;7:118. https:\/\/doi.org\/10.1186\/s13073-015-0240-5 .","journal-title":"Genome Med"},{"key":"354_CR12","doi-asserted-by":"publisher","unstructured":"\u2018t Hoen PA, Peter A C, Friedl\u00e4nder MR, Alml\u00f6f J, Sammeth M, Pulyakhina I, Anvar SY, et al. Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat Biotechnol. 2013;31:1015\u20131022. https:\/\/doi.org\/10.1038\/nbt.2702 .","DOI":"10.1038\/nbt.2702"},{"key":"354_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/bioinformatics\/btp692","volume":"26","author":"B Li","year":"2010","unstructured":"Li B, Ruotti V, Stewart RM, Thomson JA, Dewey CN. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics. 2010;26:493\u2013500. https:\/\/doi.org\/10.1093\/bioinformatics\/btp692 .","journal-title":"Bioinformatics"},{"key":"354_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2","author":"H Wickham","year":"2009","unstructured":"Wickham H. ggplot2. New York: Springer New York; 2009."},{"key":"354_CR15","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 .","journal-title":"Genome Biol"},{"key":"354_CR16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"KG Ardlie","year":"2015","unstructured":"Ardlie KG, Deluca DS, Segre AV, Sullivan TJ, Young TR, Gelfand ET, et al. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348:648\u201360. https:\/\/doi.org\/10.1126\/science.1262110 .","journal-title":"Science"},{"key":"354_CR17","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. https:\/\/doi.org\/10.1126\/science.1260419 .","journal-title":"Science"},{"key":"354_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1471-2164-13-115","volume":"13","author":"J Kim","year":"2012","unstructured":"Kim J, Zhao K, Jiang P, Lu Z-X, Wang J, Murray JC, Xing Y. Transcriptome landscape of the human placenta. BMC Genomics. 2012;13:115. https:\/\/doi.org\/10.1186\/1471-2164-13-115 .","journal-title":"BMC Genomics"},{"key":"354_CR19","doi-asserted-by":"publisher","first-page":"e0118528","DOI":"10.1371\/journal.pone.0118528","volume":"10","author":"KL Hoek","year":"2015","unstructured":"Hoek KL, Samir P, Howard LM, Niu X, Prasad N, Galassie A, et al. A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination. PLoS One. 2015;10:e0118528. https:\/\/doi.org\/10.1371\/journal.pone.0118528 .","journal-title":"PLoS One"},{"key":"354_CR20","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/art.39135","volume":"67","author":"K Jiang","year":"2015","unstructured":"Jiang K, Zhu L, Buck MJ, Chen Y, Carrier B, Liu T, Jarvis JN. Disease-associated single-nucleotide polymorphisms from noncoding regions in juvenile idiopathic arthritis are located within or adjacent to functional genomic elements of human neutrophils and CD4+ T cells. Arthritis Rheumatol. 2015;67:1966\u201377. https:\/\/doi.org\/10.1002\/art.39135 .","journal-title":"Arthritis Rheumatol"},{"key":"354_CR21","doi-asserted-by":"publisher","first-page":"e1002552","DOI":"10.1371\/journal.pgen.1002552","volume":"8","author":"DL Eizirik","year":"2012","unstructured":"Eizirik DL, Sammeth M, Bouckenooghe T, Bottu G, Sisino G, Igoillo-Esteve M, et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 2012;8:e1002552. https:\/\/doi.org\/10.1371\/journal.pgen.1002552 .","journal-title":"PLoS Genet"},{"key":"354_CR22","doi-asserted-by":"publisher","first-page":"e81809","DOI":"10.1371\/journal.pone.0081809","volume":"8","author":"A Kissopoulou","year":"2013","unstructured":"Kissopoulou A, Jonasson J, Lindahl TL, Osman A. Next generation sequencing analysis of human platelet PolyA+ mRNAs and rRNA-depleted total RNA. PLoS One. 2013;8:e81809. https:\/\/doi.org\/10.1371\/journal.pone.0081809 .","journal-title":"PLoS One"},{"key":"354_CR23","doi-asserted-by":"publisher","first-page":"1251033","DOI":"10.1126\/science.1251033","volume":"345","author":"L Chen","year":"2014","unstructured":"Chen L, Kostadima M, JHA M, Canu G, Garcia SP, Turro E, et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science. 2014;345:1251033. https:\/\/doi.org\/10.1126\/science.1251033 .","journal-title":"Science"},{"key":"354_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/ni.3299","volume":"16","author":"D Casero","year":"2015","unstructured":"Casero D, Sandoval S, Seet CS, Scholes J, Zhu Y, Ha VL, et al. Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nat Immunol. 2015;16:1282\u201391. https:\/\/doi.org\/10.1038\/ni.3299 .","journal-title":"Nat Immunol"},{"key":"354_CR25","unstructured":"Stemcell Technologies. Frequencies of Cell Types in Human Peripheral Blood. https:\/\/www.stemcell.com\/media\/files\/wallchart\/WA10006-Frequencies_Cell_Types_Human_Peripheral_Blood.pdf . \u200bAccessed 21 Mar 2018."},{"key":"354_CR26","doi-asserted-by":"publisher","unstructured":"Zhou R, Caspi RR. Ocular immune privilege. F1000 Biol Rep. 2010; https:\/\/doi.org\/10.3410\/B2-3 .","DOI":"10.3410\/B2-3"},{"key":"354_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","volume":"213","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006;213:48\u201365. https:\/\/doi.org\/10.1111\/j.1600-065X.2006.00441.x .","journal-title":"Immunol Rev"},{"key":"354_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-065X.2006.00438.x","volume":"213","author":"M Fijak","year":"2006","unstructured":"Fijak M, Meinhardt A. The testis in immune privilege. Immunol Rev. 2006;213:66\u201381. https:\/\/doi.org\/10.1111\/j.1600-065X.2006.00438.x .","journal-title":"Immunol Rev"},{"key":"354_CR29","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/cdd.2015.171","volume":"23","author":"C Sciorati","year":"2016","unstructured":"Sciorati C, Rigamonti E, Manfredi AA, Rovere-Querini P. Cell death, clearance and immunity in the skeletal muscle. Cell Death Differ. 2016;23:927\u201337. https:\/\/doi.org\/10.1038\/cdd.2015.171 .","journal-title":"Cell Death Differ"},{"key":"354_CR30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.160.1.171","volume":"160","author":"A Neisig","year":"1998","unstructured":"Neisig A, Melief CJ, Neefjes J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol. 1998;160:171\u20139.","journal-title":"J Immunol"},{"key":"354_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature09914","volume":"472","author":"S Kulkarni","year":"2011","unstructured":"Kulkarni S, Savan R, Qi Y, Gao X, Yuki Y, Bass SE, et al. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature. 2011;472:495\u20138. https:\/\/doi.org\/10.1038\/nature09914 .","journal-title":"Nature"},{"key":"354_CR32","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.4049\/jimmunol.180.12.7804","volume":"180","author":"MR Schaefer","year":"2008","unstructured":"Schaefer MR, Williams M, Kulpa DA, Blakely PK, Yaffee AQ, Collins KL. A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages. J Immunol. 2008;180:7804\u201317. https:\/\/doi.org\/10.4049\/jimmunol.180.12.7804 .","journal-title":"J Immunol"},{"key":"354_CR33","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.3748\/wjg.v21.i42.12125","volume":"21","author":"S Blasco-Algora","year":"2015","unstructured":"Blasco-Algora S, Masegosa-Ataz J, Guti\u00e9rrez-Garc\u00eda ML, Alonso-L\u00f3pez S, Fern\u00e1ndez-Rodr\u00edguez CM. Acute-on-chronic liver failure: pathogenesis, prognostic factors and management. World J Gastroenterol. 2015;21:12125\u201340. https:\/\/doi.org\/10.3748\/wjg.v21.i42.12125 .","journal-title":"World J Gastroenterol"},{"key":"354_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/mus.880150307","volume":"15","author":"C Cifuentes-Diaz","year":"1992","unstructured":"Cifuentes-Diaz C, Delaporte C, Dautr\u00e9aux B, Charron D, Fardeau M. Class II MHC antigens in normal human skeletal muscle. Muscle Nerve. 1992;15:295\u2013302. https:\/\/doi.org\/10.1002\/mus.880150307 .","journal-title":"Muscle Nerve"},{"key":"354_CR35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.149.2.661","volume":"149","author":"N Goebels","year":"1992","unstructured":"Goebels N, Michaelis D, Wekerle H, Hohlfeld R. Human myoblasts as antigen-presenting cells. J Immunol. 1992;149:661\u20137.","journal-title":"J Immunol"},{"key":"354_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2012.00258","volume":"3","author":"S Rajagopalan","year":"2012","unstructured":"Rajagopalan S, Long EO. KIR2DL4 (CD158d): an activation receptor for HLA-G. Front Immunol. 2012;3:258. https:\/\/doi.org\/10.3389\/fimmu.2012.00258 .","journal-title":"Front Immunol"},{"key":"354_CR37","doi-asserted-by":"publisher","first-page":"e92889","DOI":"10.1371\/journal.pone.0092889","volume":"9","author":"G-D Yao","year":"2014","unstructured":"Yao G-D, Shu Y-M, Shi S-L, Peng Z-F, Song W-Y, Jin H-X, et al. Expression and potential roles of HLA-G in human spermatogenesis and early embryonic development. PLoS One. 2014;9:e92889. https:\/\/doi.org\/10.1371\/journal.pone.0092889 .","journal-title":"PLoS One"},{"key":"354_CR38","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2337\/db05-0731","volume":"55","author":"V Cirulli","year":"2006","unstructured":"Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes. 2006;55:1214\u201322.","journal-title":"Diabetes"},{"key":"354_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0198-8859(01)00373-1","volume":"63","author":"C Pangault","year":"2002","unstructured":"Pangault C, Le Friec G, Caulet-Maugendre S, Lena H, Amiot L, Guilloux V, et al. Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum Immunol. 2002;63:83\u201390.","journal-title":"Hum Immunol"},{"key":"354_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/359748","volume":"2014","author":"N Rouas-Freiss","year":"2014","unstructured":"Rouas-Freiss N, Moreau P, Lemaoult J, Carosella ED. The dual role of HLA-G in Cancer. J Immunol Res. 2014;2014:1\u201310. https:\/\/doi.org\/10.1155\/2014\/359748 .","journal-title":"J Immunol Res"},{"key":"354_CR41","doi-asserted-by":"publisher","first-page":"907092","DOI":"10.1155\/2010\/907092","volume":"2010","author":"G Pietra","year":"2010","unstructured":"Pietra G, Romagnani C, Manzini C, Moretta L, Mingari MC. The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. J Biomed Biotechnol. 2010;2010:907092. https:\/\/doi.org\/10.1155\/2010\/907092 .","journal-title":"J Biomed Biotechnol"},{"key":"354_CR42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.141.3.897","volume":"141","author":"BH Koller","year":"1988","unstructured":"Koller BH, Geraghty DE, Shimizu Y, DeMars R, Orr HT. HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol. 1988;141:897\u2013904.","journal-title":"J Immunol"},{"key":"354_CR43","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","volume":"95","author":"N Lee","year":"1998","unstructured":"Lee N, Llano M, Carretero M, Ishitani A, Navarro F, L\u00f3pez-Botet M, Geraghty DE. HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A. Proc Natl Acad Sci U S A. 1998;95:5199\u2013204.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"354_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.lungcan.2011.04.006","volume":"74","author":"A Lin","year":"2011","unstructured":"Lin A, Zhang X, Ruan Y-Y, Wang Q, Zhou W-J, Yan W-H. HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. Lung Cancer. 2011;74:504\u20139. https:\/\/doi.org\/10.1016\/j.lungcan.2011.04.006 .","journal-title":"Lung Cancer"},{"key":"354_CR45","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.humimm.2013.03.002","volume":"74","author":"J-G Zhang","year":"2013","unstructured":"Zhang J-G, Zhang X, Lin A, Yan W-H. Lesion HLA-F expression is irrelevant to prognosis for patients with gastric cancer. Hum Immunol. 2013;74:828\u201332. https:\/\/doi.org\/10.1016\/j.humimm.2013.03.002 .","journal-title":"Hum Immunol"},{"key":"354_CR46","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S0198-8859(00)00198-1","volume":"61","author":"SJ Gobin","year":"2000","unstructured":"Gobin SJ, van den Elsen PJ. Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol. 2000;61:1102\u20137.","journal-title":"Hum Immunol"},{"key":"354_CR47","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/eji.200424964","volume":"34","author":"S LeibundGut-Landmann","year":"2004","unstructured":"LeibundGut-Landmann S, Waldburger J-M, Krawczyk M, Otten LA, Suter T, Fontana A, et al. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol. 2004;34:1513\u201325. https:\/\/doi.org\/10.1002\/eji.200424964 .","journal-title":"Eur J Immunol"},{"key":"354_CR48","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri3339","volume":"12","author":"KS Kobayashi","year":"2012","unstructured":"Kobayashi KS, van den Elsen PJ. NLRC5: a key regulator of MHC class I-dependent immune responses. Nat Rev Immunol. 2012;12:813\u201320. https:\/\/doi.org\/10.1038\/nri3339 .","journal-title":"Nat Rev Immunol"},{"key":"354_CR49","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1182\/blood-2006-06-030213","volume":"109","author":"S Coupel","year":"2007","unstructured":"Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou J-P, Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood. 2007;109:2806\u201314. https:\/\/doi.org\/10.1182\/blood-2006-06-030213 .","journal-title":"Blood"},{"key":"354_CR50","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/rheumatology\/keq418","volume":"50","author":"I Prigione","year":"2011","unstructured":"Prigione I, Penco F, Martini A, Gattorno M, Pistoia V, Morandi F. HLA-G and HLA-E in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2011;50:966\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/keq418 .","journal-title":"Rheumatology (Oxford)"},{"key":"354_CR51","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/eji.200323986","volume":"33","author":"MD Chiesa","year":"2003","unstructured":"Chiesa MD, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94\/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol. 2003;33:1657\u201366. https:\/\/doi.org\/10.1002\/eji.200323986 .","journal-title":"Eur J Immunol"},{"key":"354_CR52","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/eji.201040348","volume":"40","author":"N Lee","year":"2010","unstructured":"Lee N, Ishitani A, Geraghty DE. HLA-F is a surface marker on activated lymphocytes. Eur J Immunol. 2010;40:2308\u201318.","journal-title":"Eur J Immunol"},{"key":"354_CR53","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.bbmt.2011.06.004","volume":"17","author":"D Focosi","year":"2011","unstructured":"Focosi D, Zucca A, Scatena F. The role of anti-HLA antibodies in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1585\u20138. https:\/\/doi.org\/10.1016\/j.bbmt.2011.06.004 .","journal-title":"Biol Blood Marrow Transplant"},{"key":"354_CR54","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1084\/jem.181.4.1459","volume":"181","author":"KL Wright","year":"1995","unstructured":"Wright KL. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med. 1995;181:1459\u201371. https:\/\/doi.org\/10.1084\/jem.181.4.1459 .","journal-title":"J Exp Med"},{"key":"354_CR55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood-2013-03-478255","volume":"122","author":"H Torikai","year":"2013","unstructured":"Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y, et al. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood. 2013;122:1341\u20139. https:\/\/doi.org\/10.1182\/blood-2013-03-478255 .","journal-title":"Blood"},{"key":"354_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2407-14-486","volume":"14","author":"MS Reimers","year":"2014","unstructured":"Reimers MS, Engels CC, Putter H, Morreau H, Liefers GJ, van de Velde CJ, PJK K. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer. 2014;14:486. https:\/\/doi.org\/10.1186\/1471-2407-14-486 .","journal-title":"BMC Cancer"},{"key":"354_CR57","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1093\/nar\/gku555","volume":"42","author":"A-E Saliba","year":"2014","unstructured":"Saliba A-E, Westermann AJ, Gorski SA, Vogel J. Single-cell RNA-seq: advances and future challenges. Nucleic Acids Res. 2014;42:8845\u201360. https:\/\/doi.org\/10.1093\/nar\/gku555 .","journal-title":"Nucleic Acids Res"},{"key":"354_CR58","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1093\/hmg\/ddu114","volume":"23","author":"M Li","year":"2014","unstructured":"Li M, Jia C, Kazmierkiewicz KL, Bowman AS, Tian L, Liu Y, et al. Comprehensive analysis of gene expression in human retina and supporting tissues. Hum Mol Genet. 2014;23:4001\u201314. https:\/\/doi.org\/10.1093\/hmg\/ddu114 .","journal-title":"Hum Mol Genet"},{"key":"354_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2164-14-486","volume":"14","author":"MH Farkas","year":"2013","unstructured":"Farkas MH, Grant GR, White JA, Sousa ME, Consugar MB, Pierce EA. Transcriptome analyses of the human retina identify unprecedented transcript diversity and 3.5 Mb of novel transcribed sequence via significant alternative splicing and novel genes. BMC Genomics. 2013;14:486. https:\/\/doi.org\/10.1186\/1471-2164-14-486 .","journal-title":"BMC Genomics"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-018-0354-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T22:36:43Z","timestamp":1693607803000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-018-0354-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/s12920-018-0354-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"14 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"US is co-founder and employee of BioNTech AG (Mainz, Germany). JCC is now employed by Agenus UK Limited. These companies are developing immunotherapies. The remaining authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"36"}}